Abstract:INTRODUCTION: Solid organ transplant recipients are at increased risk of de novomalignancies, in some cases up to 15.6%. Data regarding pancreatic cancer following liver transplantation is limited. We aim to evaluate the incidence of pancreatic adenocarcinoma among liver transplant recipients in the United States. Describe survival in those patients and identify subgroup of patients at increased risk. METHODS: We examined the United Network of Organ Sharing (UNOS) database and identified patients with pancreatic adenocarcinoma who underwent liver transplant between 1988 and 2016. Patients 18 years of age and older were included. Demographics, primary diagnosis and survival data were recorded. Kaplan-Meier survival analyses and log-rank tests were performed. RESULTS: In the UNOS database, survival data regarding 142,488 patients was available and the cause of death was identified in 14,533 liver transplant recipients. A total of 140 patients developed pancreatic adenocarcinoma after liver transplantation. Most common indications for transplantations were Hepatitis C, alcohol cirrhosis and hepatocellular carcinoma (25 [17.9%], 24 [17.1%] and 9 [6.4%] respectively). Annual incidence was 16 pancreatic cancer cases per 100,000 transplant recipients. Compared to national annual incidence of 12.9 cancer cases per 100,000 patients, the relative risk was 1.23 (95% CI 0.59–2.56). Compared to other liver transplant recipients, those who developed pancreatic cancer were older and transplanted earlier in the time period evaluated (P < 0.001 and P = 0.002 respectively). Gender, ethnicity, BMI, and primary diagnosis (i.e., transplant indication) were not significantly different among groups. Patient survival was significantly lower in patients who developed pancreatic adenocarcinoma (Log-rank test P < 0.001) (Figure 1). CONCLUSION: Analysis of the UNOS database showed that pancreatic adenocarcinoma is increased among liver transplant recipients without reaching statistical significance. Primary indications for transplantation and demographics were similar among both groups. Our findings suggest that pancreatic adenocarcinoma is more likely associated to long-standing immunosuppression and non-traditional risk factors rather than alcohol consumption or obesity. Further studies describing the natural history of pancreatic cancer after solid organ transplantation are suggested.

S1916 Prevalence of Different Malignancies Among Liver Transplant Recipients: A Nationwide Study

Role of the Immune System in Liver Transplantation and Its Implications for Therapeutic Interventions

Incidence, risk factors and outcomes of de novo malignancies post liver transplantation

Dermatological Disorders following Liver Transplantation: An Update.

Dermatological Disorders Following Liver Transplantation: an Update

Metachronous Pulmonary and Adrenal Metastases after Liver Transplantation for Hepatocarcinoma

Clinical Analysis of Malignant Tumors in Recipients of Renal Transplantation

Malignancies After Lung Transplantation

De Novo Malignancy after Liver Transplantation: a Single-Center Experience of 14 Cases.

S1678 A 13-Year Nationwide Analysis of Nocardia and Actinomyces Infection Outcomes in Liver Transplant Recipients

Increasing Prevalence and High Survival Rate of Liver Transplanted Patients with NASH and PSC Cirrhosis

Survival following liver transplantation: A population-based nested case-control study

Low recurrence of preexisting extrahepatic malignancies after liver transplantation

Chronological alterations in de novo malignancies after living‐donor liver transplantation: A cohort study of 1781 recipients using annual comparisons of standardized incidence ratios

De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations

Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Systematic Review of Real-World Evidence

Long-Term Outcomes of Incidental Liver Malignancies in Simultaneous Liver-Kidney Transplant Recipients

Pancreatic Adenocarcinoma Following Liver Transplantation: UNOS Data Analysis

Spectrum Of De Novo Cancers And Predictors In Liver Transplantation: Analysis Of The Scientific Registry Of Transplant Recipients Database

Clinical Analysis of De Novo Neoplasms in Patients after Liver Transplantation

Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long‐Term Survival